TipRanks
Viatris (DE:VIA)
XETRA:VIA
Germany Market
VIA
Viatris
RESEARCH TOOLSreports

Viatris (VIA) Stock Forecast & Price Target

13 Followers
See the Price Targets and Ratings of:

VIA Analyst Ratings

Moderate Buy
9Ratings
Moderate Buy
5 Buy
3 Hold
1 Sell
Based on 9 analysts giving stock ratings to
Viatris
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

VIA Stock 12 Month Forecast

Average Price Target

€17.00
▲(17.31% Upside)
Based on 9 Wall Street analysts offering 12 month price targets for Viatris in the last 3 months. The average price target is €17.00 with a high forecast of €21.86 and a low forecast of €11.36. The average price target represents a 17.31% change from the last price of €14.49.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"7":"€7","22":"€22","10.75":"€10.75","14.5":"€14.5","18.25":"€18.25"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":21.85524825,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">€21.86</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":16.998526416666664,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">€17.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":11.36472909,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">€11.36</span>\n  </div></div>","useHTML":true}}],"tickPositions":[7,10.75,14.5,18.25,22],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Dec<br/>2025","6":"Mar<br/>2026","9":"Jun<br/>2026","12":"Sep<br/>2026","25":"Sep<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,14.36,14.936557557692307,15.513115115384615,16.089672673076922,16.66623023076923,17.242787788461538,17.819345346153845,18.395902903846153,18.97246046153846,19.54901801923077,20.125575576923076,20.702133134615384,21.27869069230769,{"y":21.85524825,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,14.36,14.562963570512819,14.76592714102564,14.96889071153846,15.171854282051282,15.374817852564101,15.577781423076921,15.780744993589742,15.983708564102562,16.18667213461538,16.389635705128203,16.592599275641025,16.795562846153842,{"y":16.998526416666664,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,14.36,14.129594545384615,13.89918909076923,13.668783636153846,13.43837818153846,13.207972726923076,12.977567272307692,12.747161817692309,12.516756363076924,12.28635090846154,12.055945453846155,11.82553999923077,11.595134544615386,{"y":11.36472909,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":8.516,"date":1756684800000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":8.365,"date":1759276800000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":8.72,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":8.988,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":10.297,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":11.117,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":12.519,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":11.616,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":12.719,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":13.546,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":14.201,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":15.122,"date":1785542400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":14.36,"date":1788220800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target€21.86Average Price Target€17.00Lowest Price Target€11.36
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Oppenheimer Analyst forecast on DE:VIA
Unknown Analyst
Oppenheimer
Not Ranked
Oppenheimer
€21.86
Buy
50.83%
Upside
Initiated
09/23/26
Viatris initiated with an Outperform at OppenheimerViatris initiated with an Outperform at Oppenheimer
Piper Sandler Analyst forecast on DE:VIA
David Amsellem
Piper Sandler
Piper Sandler
€10.49→€11.36
Hold
-21.57%
Downside
Reiterated
09/16/26
Analysts Offer Insights on Healthcare Companies: Viatris (NASDAQ: VTRS) and Vera Therapeutics (NASDAQ: VERA)
Leerink Partners Analyst forecast on DE:VIA
Daniel Clark
Leerink Partners
Leerink Partners
€17.48
Buy
20.66%
Upside
Initiated
09/09/26
Leerink sees growth for Viatris, starts at OutperformLeerink sees growth for Viatris, starts at Outperform
Argus Research Analyst forecast on DE:VIA
Jasper Hellweg
Argus Research
Argus Research
€13.11→€17.48
Buy
20.66%
Upside
Reiterated
09/08/26
Viatris price target raised to $20 from $15 at ArgusViatris price target raised to $20 from $15 at Argus
Barclays Analyst forecast on DE:VIA
Glen Santangelo
Barclays
Barclays
€19.23
Buy
32.73%
Upside
Reiterated
08/17/26
Barclays Keeps Their Buy Rating on Viatris (VTRS)
J.P. Morgan Analyst forecast on DE:VIA
Chris Schott
J.P. Morgan
J.P. Morgan
€15.74
Hold
8.60%
Upside
Reiterated
08/10/26
Analysts Have Conflicting Sentiments on These Healthcare Companies: Orthofix Medical (NASDAQ: OFIX), Rhythm Pharmaceuticals (NASDAQ: RYTM) and Viatris (NASDAQ: VTRS)
UBS Analyst forecast on DE:VIA
Ashwani Verma
UBS
UBS
€20.11
Buy
38.76%
Upside
Reiterated
08/07/26
Analysts Offer Insights on Healthcare Companies: Warby Parker (NYSE: WRBY), Viatris (NASDAQ: VTRS) and Fisher & Paykel Healthcare Corporation Limited (Other OTC: FSPKF)
Goldman Sachs Analyst forecast on DE:VIA
Salveen Richter
Goldman Sachs
Goldman Sachs
€15.74→€17.48
Hold
20.66%
Upside
Reiterated
08/06/26
Analysts Offer Insights on Healthcare Companies: Viatris (NASDAQ: VTRS), Immunocore Holdings (NASDAQ: IMCR) and Praxis Precision Medicines (NASDAQ: PRAX)
Bank of America Securities Analyst forecast on DE:VIA
Jason Gerberry
Bank of America Securities
Bank of America Securities
€12.24
Sell
-15.54%
Downside
Reiterated
07/10/26
Bank of America Securities Keeps Their Sell Rating on Viatris (VTRS)
Truist Financial Analyst forecast on DE:VIA
Les Sulewski
Truist Financial
Truist Financial
€15.74→€17.48
Buy
20.66%
Upside
Reiterated
05/08/26
Viatris (VTRS) Gets a Buy from Truist Financial
Jefferies Analyst forecast on DE:VIA
Unknown Analyst
Jefferies
Not Ranked
Jefferies
€14.86
Buy
2.56%
Upside
Reiterated
03/20/26
Jefferies Keeps Their Buy Rating on Viatris (VTRS)
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Oppenheimer Analyst forecast on DE:VIA
Unknown Analyst
Oppenheimer
Not Ranked
Oppenheimer
€21.86
Buy
50.83%
Upside
Initiated
09/23/26
Viatris initiated with an Outperform at OppenheimerViatris initiated with an Outperform at Oppenheimer
Piper Sandler Analyst forecast on DE:VIA
David Amsellem
Piper Sandler
Piper Sandler
€10.49→€11.36
Hold
-21.57%
Downside
Reiterated
09/16/26
Analysts Offer Insights on Healthcare Companies: Viatris (NASDAQ: VTRS) and Vera Therapeutics (NASDAQ: VERA)
Leerink Partners Analyst forecast on DE:VIA
Daniel Clark
Leerink Partners
Leerink Partners
€17.48
Buy
20.66%
Upside
Initiated
09/09/26
Leerink sees growth for Viatris, starts at OutperformLeerink sees growth for Viatris, starts at Outperform
Argus Research Analyst forecast on DE:VIA
Jasper Hellweg
Argus Research
Argus Research
€13.11→€17.48
Buy
20.66%
Upside
Reiterated
09/08/26
Viatris price target raised to $20 from $15 at ArgusViatris price target raised to $20 from $15 at Argus
Barclays Analyst forecast on DE:VIA
Glen Santangelo
Barclays
Barclays
€19.23
Buy
32.73%
Upside
Reiterated
08/17/26
Barclays Keeps Their Buy Rating on Viatris (VTRS)
J.P. Morgan Analyst forecast on DE:VIA
Chris Schott
J.P. Morgan
J.P. Morgan
€15.74
Hold
8.60%
Upside
Reiterated
08/10/26
Analysts Have Conflicting Sentiments on These Healthcare Companies: Orthofix Medical (NASDAQ: OFIX), Rhythm Pharmaceuticals (NASDAQ: RYTM) and Viatris (NASDAQ: VTRS)
UBS Analyst forecast on DE:VIA
Ashwani Verma
UBS
UBS
€20.11
Buy
38.76%
Upside
Reiterated
08/07/26
Analysts Offer Insights on Healthcare Companies: Warby Parker (NYSE: WRBY), Viatris (NASDAQ: VTRS) and Fisher & Paykel Healthcare Corporation Limited (Other OTC: FSPKF)
Goldman Sachs Analyst forecast on DE:VIA
Salveen Richter
Goldman Sachs
Goldman Sachs
€15.74→€17.48
Hold
20.66%
Upside
Reiterated
08/06/26
Analysts Offer Insights on Healthcare Companies: Viatris (NASDAQ: VTRS), Immunocore Holdings (NASDAQ: IMCR) and Praxis Precision Medicines (NASDAQ: PRAX)
Bank of America Securities Analyst forecast on DE:VIA
Jason Gerberry
Bank of America Securities
Bank of America Securities
€12.24
Sell
-15.54%
Downside
Reiterated
07/10/26
Bank of America Securities Keeps Their Sell Rating on Viatris (VTRS)
Truist Financial Analyst forecast on DE:VIA
Les Sulewski
Truist Financial
Truist Financial
€15.74→€17.48
Buy
20.66%
Upside
Reiterated
05/08/26
Viatris (VTRS) Gets a Buy from Truist Financial
Jefferies Analyst forecast on DE:VIA
Unknown Analyst
Jefferies
Not Ranked
Jefferies
€14.86
Buy
2.56%
Upside
Reiterated
03/20/26
Jefferies Keeps Their Buy Rating on Viatris (VTRS)
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
MDWDMediwound
OCULOcular Therapeutix
GHGuardant Health
HROWHarrow Health
DNLIDenali Therapeutics
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Viatris

3 Months
Les SulewskiTruist Financial
Success Rate
7/8 ratings generated profit
88%
Average Return
+19.80%
Copying Les Sulewski's trades and holding each position for 3 Months would result in 87.50% of your transactions generating a profit, with an average return of +19.80% per trade.
1 Year
Les SulewskiTruist Financial
Success Rate
8/8 ratings generated profit
100%
Average Return
+41.46%
Copying Les Sulewski's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +41.46% per trade.
2 Years
Les SulewskiTruist Financial
Success Rate
8/8 ratings generated profit
100%
Average Return
+41.46%
Copying Les Sulewski's trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +41.46% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

VIA Analyst Recommendation Trends

Rating
May 26
Jun 26
Jul 26
Aug 26
Sep 26
Strong Buy
0
0
0
0
0
Buy
7
4
3
3
6
Hold
5
4
5
4
4
Sell
0
0
1
1
1
Strong Sell
0
0
0
0
0
total
12
8
9
8
11
In the current month, VIA has received 6 Buy Ratings, 4 Hold Ratings, and 1 Sell Ratings. VIA average Analyst price target in the past 3 months is 17.00.
Each month's total comprises the sum of three months' worth of ratings.

VIA Financial Forecast

VIA Earnings Forecast

Next quarter’s earnings estimate for VIA is €0.56 with a range of €0.54 to €0.60. The previous quarter’s EPS was €0.60. VIA beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year VIA has Performed in-line its overall industry.
Next quarter’s earnings estimate for VIA is €0.56 with a range of €0.54 to €0.60. The previous quarter’s EPS was €0.60. VIA beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year VIA has Performed in-line its overall industry.

VIA Sales Forecast

Next quarter’s sales forecast for VIA is €3.32B with a range of €3.27B to €3.38B. The previous quarter’s sales results were €3.29B. VIA beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year VIA has Performed in-line its overall industry.
Next quarter’s sales forecast for VIA is €3.32B with a range of €3.27B to €3.38B. The previous quarter’s sales results were €3.29B. VIA beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year VIA has Performed in-line its overall industry.

VIA Stock Forecast FAQ

What is DE:VIA’s average 12-month price target, according to analysts?
Based on analyst ratings, Viatris’s 12-month average price target is 17.00.
    What is DE:VIA’s upside potential, based on the analysts’ average price target?
    Viatris has 17.31% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is Viatris a Buy, Sell or Hold?
          Viatris has a consensus rating of Moderate Buy, which is based on 5 buy ratings, 3 hold ratings and 1 sell ratings.
            What is Viatris’s share price target?
            The average share price target for Viatris is 17.00. This is based on 9 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst share price target is €21.86 ,and the lowest forecast is €11.36. The average share price target represents 17.31% Increase from the current price of €14.49.
              What do analysts say about Viatris?
              Viatris’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 9 Wall Streets Analysts.
                How can I buy shares of Viatris?
                To buy shares of DE:VIA, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.